Follow the 이오플로우 stock price and the full directors' dealings record of the company, a publicly traded company based in South Korea. Shares are listed on KR KR, under the supervision of DART (FSS). Operating in the Health Care sector, 이오플로우 has recorded 88 public disclosures. The latest transaction was filed on 28 May 2026 (Purchase). Among the most active insiders: 타이거자산운용투자일임. Every trade is openly available.
88
Insider Decl.
n/a
Thresholds
€17,550
39 ops.
Buy Volume
n/a
5 ops.
Sell Volume
22Σ signal
Buys €17,550n/a Sells
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
이오플로우 is a company in the healthcare and pharmaceutical sector, listed on the XKRX market. It focuses on developing innovative solutions for diabetes management.